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INTRODUCTION 
Alterations in glucose metabolism have been observed 
to occur in a variety of infectious processes such as endo-
toxemia and septicemia. The metabolic response to infec-
tion is characterized by a biphasic pattern in plasma glu-
cose levels. The hyperglycemia manifested in early endo-
toxemia or sepsis has been attributed to an increase in he-
patic gluconeogenesis, glycogenolysis and increased avail-
ability of gluconeogenic substrates, such as alanine and 
lactate. This primarily catabolic response has been as-
cribed to an elevation in glucagon, catecholamine, gluco-
corticoid and growth hormone levels. 
In contrast, the terminal stage of gram negative 
sepsis and endotoxicosis is marked by a state of progress-
ive hyperinsulinism which, if left unchecked, inevitably 
leads to profound hypoglycemia and death. Three basic 
mechanisms have been thought to contribute to this energy 
substrate depletion. Firstly, the increase in hepatic 
glycogenolysis is a transient one. The prolonged and 
heightened sympathetic drive exhausts the available gly-
cogen stores early in the infectious process. Second, and 
perhaps more important in the progression to hypoglycemia, 
is the depression of hepatic gluconeogenesis. Lastly, the 
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increased disappearance of glucose from the body glucose 
pool, i.e., enhanced peripheral tissue glucose oxidation. 
The latter is of particular interest in this study. 
It has been shown that different components of the 
body act as glucose sinks in the agonal stages of endo-
toxin and septic shock. The liver, diaphragm, spleen, 
epididymal fat pads and certain blood components have all 
been demonstrated to increase their energy expenditure 
during the infectious process. Work from this laboratory 
has shown that in endotoxemia, the sensitivity of adipose 
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tissue to a given stimulus of insulin is elevated. Whether 
the same is true in experimental septic shock is a question 
that this study will seek to address. 
Recent work from our laboratory has suggested another 
factor which may partially explain the increase in glucose 
utilization; non-suppressible insulin-like activity (NSILA). 
NSILA in the serum is a glycoprotein of non-pancreatic 
origin and is physicochemically distinct from insulin. An 
increase in NSILA levels has been demonstrated to occur in 
rats in late endotoxic shock (14). This increase was ac-
companied by hypoglycemia and hypoinsulinema. 
This study will also investigate the role of NSILA 
in the septic shock syndrome. Whether it contributes to 
the progression of hypoglycemia by altering tissue glucose 
will be ascertained. 
LITERATURE REVIEW 
A survey by Martin (40) in 1969 revealed a disturbing 
trend in the frequency of bacteremias in American hospitals. 
By his estimate, in 1968, 1% of hospital admissions de-
veloped bacteremia and 60% of these were due to gram neg-
ative bacteria. At least 250,000 cases of infection oc-
curred leading to approximately 50,000 deaths. A more 
recent estimate by Wolff and Bennett (75) in 1974 puts the 
number of documented cases of gram negative sepsis at 
71,000 per year with a resultant 18,000 deaths. In yet 
another study dealing with postoperative sepsis and total 
hospital infection rate, 3.9% of surgical patients develop-
ed postoperative sepsis and 13.5% was the total infection 
rate (72). McCabe (42) has shown that the incidence of sep-
sis has increased arithmetically over 2 decades until 1974. 
Clearly, the frequency of sepsis has been on the rise 
due to the increasing proportion of elderly, chronically 
ill patients, increased number and complexity of surgical 
operations, ineffective antibiotic therapy, etc. This 
alarming fact has spurred the progression of ventures into 
the various facets of sepsis. This study will be concern-
ed primarily with alterations in carbohydrate metabolism 
in the late stage of sepsis. 
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The metabolic response to infection is a dynamic 
process. It is influenced by a number of factors includ-
ing the severity and duration of illness, microorganism 
type, and physiological status of the host. These re-
sponses may also exhibit interrelated biphasic patterns. 
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Generally, the early response to infection is a cata-
bolic one. Gluconeogenesis is enhanced during sepsis by 
the stimulatory action of hormones and by the increased 
availability of gluconeogenic substrates ( 2). This early 
phase is analogous to Cuthberson's "flow" phase (12). 
This catabolic or flow phase of injury or infection is 
characterized by an increase in the metabolic rate, body 
temperature, serum insulin, catecholamine, glucose, glu-
cocorticoid, growth hormone and lactate concentrations 
( 6 2) • If the infectious process is severe or is unchecked 
and allowed to continue, an irreversible transition to a 
shock state occurs and death inevitably ensues. A marked 
hypoglycemia is characteristic of this agonal stage of in-
fection and injury. 
HYPOGLYCEMIA IN INFECTION 
Terminal hypoglycemia has been demonstrated in humans 
and a wide variety of animals including dogs, monkeys and 
rats during septic and endotoxemic episodes. Berk, et al 
( 3) observed a profound hypoglycemia (25 mg/dl) in dogs 
3 hours after an LD 70 dose of endotoxin. Filkins and 
Cornell (16) elicited a drop in plasma glucose levels from 
a mean control of 110 to 48 mg/dl 5 hours after the admin-
istration of s.enteritidis endotoxin to fed rats. Berry, 
et al ( 5) injected mice with S.typhimurium endotoxin i.p. 
and hypoglycemia resulted. Intravenous injections of live 
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microorganisms were also shown to result in a hypoglycemic 
crisis. Griffiths, et al (26) demonstrated a decrease in 
blood glucose from 90 to 70 mg/dl in dogs 4 hours following 
the i.v. injection of live E.coli. Hinshaw, et al (31) 
infused 5 baboons with live E.coli and 4 of them died in hy-
poglycemia. Wichterman, et al (74) using the rat caecal 
ligation and puncture model for sepsis showed an elevation 
of serum glucose levels (151 mg/dl) in early and depressed 
levels (20.5 mg/dl) in late sepsis. Hypoglycemia has also 
been reported in human septic shock ( 3,55). Rachwitz, 
et al (55) documented depressed glucose levels in septic 
shock patients. Similarly, Berk, et al ( 3) reported 
50 mg/dl plasma glucose value in a patient lapsing into 
septic shock. The hypoglycemia appears to be associated 
with circulatory collapse and impending death. 
In another study, Hinshaw, et al (33) injected an LD 70 
dose (1.0-1.5 mg/kg) of E.coli endotoxin into the femoral 
veins of 11 anesthetized dogs. After 300 minutes, 8 of the 
6 
11 died in hypoglycemia while the 3 survivors maintained 
their plasma glucose level at 61.7 ± 16 mg/dl. A second 
group of 9 dogs were treated with glucose following the en-
dotoxin challenge and all dogs became normoglycemic and 
survived. In baboons injected with live E.coli, Hinshaw, 
et al (31) showed that the animal's survival time was con-
tingent on its ability to maintain a stable glucose level. 
McNamara, et al (44) similarly showed improved cardiovascu-
lar function in endotoxic rabbits treated with an exogenous 
source of glucose. Berk, et al ( 3) maintained that glucose 
was indeed necessary for the survival of an animal in endo-
toxemia. 
MECHANISMS OF HYPOGLYCEMIA 
From a metabolic point of view, three mechanisms have 
been proposed to contribute to the development of hypogly-
cemia in the septic animal: (1) depletion of hepatic gly-
cogen stores, (2) depression of hepatic gluconeogenesis, 
and (3) enhanced peripheral tissue glucose oxidation. 
HEPATIC GLYCOGEN DEPLETION 
The initial metabolic response to a bacterial insult 
is increased .sympathetic drive to promote hepatic glyco-
genolysis. Evans and Zeckwer (13) injected E.coli into 
adrenalectomized rabbits and observed the development of 
hypoglycemia and convulsive death. In contrast, rats with 
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their adrenal glands intact have been shown to go through, 
as previously mentioned, a biphasic pattern in blood glu-
cose levels with an early hyperglycemia and late hypo-
glycemia ( 6, 16). Groves, et al (28) reported a concur-
rent drop in plasma glucose levels and hepatic glycogen 
content in dogs injected with live E.coli. Berry, et al 
( 5) found a marked carbohydrate depletion in different 
strains of mice injected intraperitoneally with 2 mg of 
S.typhimurium endotoxin. Accompanying the blood sugar de-
crease (149 ± 6 mg % to 37 ± 13 mg %) were liver (5.5 ± 0.6 
to 0.21 ± 0.07 percent by weight) and muscle (0.33 ± 0.06 
to 0.10 ± 0.04 percent by weight) glycogen depletion. Mc-
Callum and Berry (43) observed a drop in liver glycogen 
as early as 1 hour after treatment of mice with an LD 50 
dose of endotoxin. Glycogen synthase activity was also 
shown to be depressed in fasted endotoxic rats (490 ± 54) 
as compared with fasted controls (826 ± 83). Filkins and 
Cornell (16), likewise, demonstrated liver glycogen to 
fall in both fed and fasted endotoxic rats. Hypoglycemia 
and glycogen depletion were most prominent 300 minutes post 
injection. Clearly, the decreased inflow of glucose de-
rived from glycogen into the total body glucose pool plays 
an important part in the development of hypoglycemia. 
DEPRESSED HEPATIC GLUCONEOGENESIS 
The gluconeogenic capacity of the liver is also im-
paired in infection and injury. McCallum and Berry (43) 
evaluated the gluconeogenic ability of the endotoxic mice's 
liver through the incorporation of the 14c label from 
alanine - U - 14 c into blood glucose. The total amount of 
14 c - label incorporated from both alanine - U - 14 c and 
pyruvate - 2 - 14 c into blood glucose was significantly re-
duced by endotoxin to approximately 70% of control values 
12 hours post injection. In vitro analysis on the effect 
of endotoxin on gluconeogenesis in isolated normal hepato-
cytes showed no significant impairment of function (16). 
If the isolated hepatocytes were harvested from endotoxin 
donors, however, a pointed reduction in glucose production 
in the presence of gluconeogenic substrates is seen (16). 
Wannemacher, et al (71) in an extensive study of glucose 
and alanine metabolism during bacterial infections in rats 
and rhesus monkeys showed glucose formation from gluconeo-
genic substrates to be reduced. Perfused rat livers during 
acute (24 hours after injection of 10 4 organisms) and 
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agonal (24 hours after 10 ) stages of S.pneumoniae, infec-
tion were able to produce only 12 ± 1.8 nmol glucose/g 
liver/min in the presence of 10 mM alanine as compared with 
a control value of 183 ± 20 nmol glucose/g liver/min (71). 
Glucose formation from 10 mM pyruvate by isolated hepato-
8 
9 
cytes from infected donor rats was shown to be reduced 40 
hours after the initial insult. There was no significant 
change after 24 hours. Evidently, the decreased hepatic 
gluconeogenic capacity is most pronounced during the 
agonal stage of the infectious process. 
ENHANCED PERIPHERAL TISSUE GLUCOSE OXIDATION 
In addition to the impairment of input into the blood 
glucose pool, there is also a derangement in the outflow, 
i.e. glucose utilization. This is the least understood of 
the three aforementioned mechanisms and is the area of in-
quiry in this study. Kinney (37) provided evidence to show 
the greater glucose disappearance, i.e. increased glucose 
turnover rate, in septic shock. Long, et al (39) substan-
tiated this finding by demonstrating an increase in glucose 
oxidation in septic patients. Ryan, et al (63) induced 
general peritonitis in rats through caecal ligation and 
found a 3-fold increase in the adipose tissue glucose oxi-
dation of septic fasted rats as compared with normal 
fasted controls. The septic rat's adipose tissue pyruvate 
dehydrogenase was significantly elevated with respect to 
the fasted control group. They did not show the same re-
lationship to exist in muscle tissue. The rate of conver-
14 14 
sion of U - C glucose to co 2 and labelled glycogen by 
incubated hemidiaphragms was not significantly different 
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between the fasted septic and control groups (63). They 
concluded that muscle was preferentially combusting its 
own amino acids to increase the availability of glucose to 
obligate organs. Filkins and Figlewicz (17) were able to 
show, however, enhanced glucose oxidation in endotoxic 
hemidiaphragm, liver, spleen and epididymal fat pad. The 
difference may perhaps be attributed to the stage of shock 
at which the determinations were made. The hypoglycemia 
associated with the agonal stages of sepsis was not re-
ported by Ryan and coworkers (63). Wichterman, et al (74) 
showed this to be the case in peritonitis. There was no 
rise in soleus muscle glucose uptake in early sepsis 
(6.9 ± 0.5 umoles glucose/g/hr) vs. control (6.6 ± 0.4 
umoles/g/hr). Rats in late sepsis were, however, character-
ized by a profound hypoglycemia (20.5 ± 4.2 mg/dl), hypo-
insulinemia (21 ± 5 uU/ml) and increased glucose uptake 
(9.7 ± 0.6 umoles glucose/g/hr). Wannemacher, et al (71) 
injected rats with S.pneumoniae and F.tularensis and meas-
14 14 
ured the oxidation of 1 - C - glucose and 6 - C - glu-
case. Since glucose labelled at carbon 1 measures both 
the pentose phosphate shunt and Krebs cycle oxidation 
rates and glucose labelled at carbon 6 measures only Krebs 
cycle activity, it was possible to gauge the effects of in-
fection via the pentose phosphate shunt. There was an 
increase in the oxidation of both labelled glucoses with the 
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pentose phosphate shunt registering a greater increase. 
Thus, Wannemacher and coworkers have suggested that the in-
crease in energy utilization may be due to the increased 
activity of phagocytic cells which derive their energy from 
the oxidation of glucose through the pentose phosphate 
shunt. Recent studies have shown that components of the 
blood itself do increase their glucose utilization in endo-
toxin shock (32,36,71). Hinshaw, et al (30) have suggested 
that white blood cells are the components acting as glucose 
sinks in shock. 
The majority of the evidence suggests that there is 
a hypercatabolism of glucose by peripheral tissues. Fil-
kins and Figlewicz (17) suggested that this may partly be 
due to altered tissue responsiveness to insulin and/or 
insulin-like substances. They showed that epididymal fat 
pads from endotoxic rats had increased basal glucose oxi-
dation and, in the presence of a suprastimulatory dose in 
vitro, marked responsiveness to insulin. Ryan, et al (63) 
showed heightened adipose tissue pyruvate dehydrogenase 
activity and glucose oxidation in the epididymal fat pads 
of rats. This increase may be attributed to the high 
levels of circulating insulin they found to be present in 
the septic animal. The agonal stage of shock is, however 
characterized by hypoinsulinemia and hypercatabolism of 
glucose. It would be a worthwhile venture to investigate 
whether the altered responsiveness described by Filkins 
and Figlewicz is evident in an experimental model of gen-
eral peritonitis. 
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In addition, there has been growing evidence that in-
sulin-like substances may mediate the increased glucose 
oxidation. Berry ( 4) has shown that endotoxin stimulates 
cellular glycolysis in a fashion similar to insulin. Evis-
cerated rats subjected to hemorrhagic shock have been shown 
to deplete the glucose pool in the absence of insulin (61). 
Filkins (15) has shown that macrophage secretory products 
induce the hypercatabolism of epididymal fat pads, in vitro. 
Nies, et al (46) have reported kinin release in endotoxic 
monkeys and Haberland (29) has shown that kinins have in-
sulin-like effects on glucose transport. It is conceivable 
that, in shock where vascular permeability is compromised, 
these products leak from the capillaries into the extra-
cellular space and stimulate glucose transport. 
One such entity is non-suppressible insulin-like 
activity. In 1941, Gellhorn, Feldman and Allen showed a 
significant hypoglycemic effect to occur in hypophysec-
tomized adrenodemedullated rats following the injection of 
1 ml of human blood drawn 2~ hours after a midday meal (22). 
This was the first demonstration of insulin-like activity 
(ILA) in human blood. Insulin-like activity or insulin 
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effect was considered to be any effect obtained over and 
above that produced by insulin-free solutions, such as 
buffered saline, on both in vitro and in vivo systems (47). 
Characterization of plasma !LA progressed after the de-
velopment of more sensitive biological assay methods. 
Martin, et al (41) and Renold, et al (59) developed an iso-
lated rat adipose tissue assay, in vitro, and Gemmill (23) 
and Gemmill and Hamman (24) showed the feasibility of an 
isolated rat diaphragm bio-assay. The conversion of 
1 - 14c - glucose to 14 co 2 by rat adipose tissue was used 
as the metabolic index of blood !LA. Glucose uptake (67), 
glucose consumption and glycogen deposition (23) and net 
gas exchange were likewise employed. 
The sensitivity, specificity and accuracy of these 
bio-assay systems varied. Estimates of plasma !LA in nor-
mal fasting man ranged from 50-350 uU/ml in a study by 
Martin, et al (41) using the in vitro adipose tissue assay. 
Somewhat lower range of 30-80 uU/ml was obtained through 
the isolated rat diaphragm method (27,56,70). The consist-
ently lower value for blood insulin concentration obtained 
through the muscle bio-assay led numerous investigators to 
suggest a greater sensitivity to insulin-like substances by 
adipose tissue. 
The introduction by Yalow and Berson (76) of a radio-
immunoassay specific for insulin yielded a more precise 
serum insulin content of 20 uU/ml in the normal fasting 
subject. 
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A survey of the estimated values of blood insulin 
levels reveals a marked discrepancy to exist between bio-
assayable insulin-like activity (ILA) and immunologically 
determined immunoreactive insulin (IRI). The consensus 
was that IRI was not identical to ILA. It was believed 
that ILA represented the cumulative biological effect of 
insulin and other physicochemically distinct substances 
that mimic its actions. 
In 1958, Leonards (38) demonstrated that human serum 
ILA was only partially suppressed, if at all, by Guinea Pig 
anti Porcine Insulin Serum (GPAIS). GPAIS is a specific 
insulin inactivator which, when added in vitro to an adi-
pose tissue or muscle preparation, blocks the stimulatory 
action of insulin on glucose metabolism. Human serum ILA 
was totally suppressed with GPAIS in an isolated diaphragm 
preparation (69), whereas only a partial suppression of ILA 
was achieved in an adipose tissue assay (19). Froesch, 
et al (19) referred to the latter as "non-suppressible 
insulin-like activity" or NSILA. It was also called "atypi-
cal insulin" by Samaan, et al (65) and "bound" insulin by 
Antoniades ( 1 ) . The fraction of serum ILA that was in-
activated by GPAIS was called suppressible ILA, typical and 
free insulin ( 1 , 19, 65). The relative ratio of NSILA to 
suppressible ILA in serum was shown to be 93:7. Only 7~~ 
of total serum ILA was suppressible with anti-insulin 
serum in normal fasting subjects (19). 
SUPPRESSIBLE INSULIN-LIKE ACTIVITY 
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Suppressible !LA in normal fasting humans was shown 
by Froesch, et al (19) to be approximately 13 uU/ml. This 
basal value rose one hour after an oral glucose load to 
100 uU/ml suggesting a direct relationship between sup-
pressible ILA and plasma glucose level. Suppressible !LA 
was also shown to increase following i.v. administration of 
glucose (25) or crystalline insulin (19) into normal sub-
jects. Elevated levels of suppressible ILA were found in 
patients with active B islet cell adenomas (47) whereas 
pancreatectomized dogs exhibited none at all (68). Were 
suppressible ILA and insulin one and the same as suggested 
by the preceeding evidence? A study by Froesch, et al 
(19) found a good correlation to exist between suppressible 
ILA and IRI values in diabetic patients to suggest that 
identity does exist. Sonksen, et al (66) in a study of a 
large pool of sera, showed a significant correlation 
(r = 0.77, p less than .001) between suppressible !LA 
and insulin measured by immunoassay. They also showed no 
correlation (r = 0.25, p greater than .05) between NSILA 
and immunoreactive insulin. As a result, it is now gen-
erally accepted that bio-assayable suppressible ILA and 
IRI are indeed equivalent entities. 
NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY 
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Suppressible ILA, however, accounted for less than 
10% of the total bio-assayable ILA. Non-suppressible in-
sulin-like activity (NSILA), whose role in septic shock 
hypoglycemia is of interest to us, represents by far, the 
majority. Like insulin, NSILA stimulated glucose uptake 
and utilization in both adipose and muscle tissue. Unlike 
insulin and suppressible ILA, however, NSILA levels were 
independent of blood glucose levels and were shown not to 
be elevated in patients with diabetes or organic hyper-
insulinism (47). Perturbation of the B-cell system by the 
addition of mannoheptulose (20) produced no alterations in 
NSILA although acute changes in plasma glucose occurred. 
Oral or i.v. administration of insulin also did not result 
in a change in NSILA levels (47). 
NSILA levels were shown to increase under conditions 
of heightened energy demands. Electrically induced muscular 
hindlimb contraction of 30-minute duration resulted in a 
marked increase in leg lymph NSILA (57). Filkins (14) has 
shown elevated NSILA in rats during late endotoxemia. This 
work suggested that the escalation of NSILA may be respon-
17 
sible for the hyperinsulinemic state which leads to lethal 
hypoglycemia. Burn or surgical trauma (52), non B-cell 
tumor hypoglycemia, such as intra-abdominal fibrosarcoma 
(50) and retroperitoneal sarcoma (54) also exhibited ele-
vated NSILA. Froesch, et al (18) have suggested that the 
physiological import of serum NSILA may be manifested only 
during conditions of injury and inflammation. 
Non-suppressible ILA was shown to be a heterogenous 
entity (35). Gel chromatography of NSILA yielded two pro-
tein fractions: a main fraction with an estimated mole-
cular weight of about 100,000 daltons and a minor one (5% 
of total) with an estimated molecular weight range of 
6,000 - 10,000. Only the minor fraction was soluble in 
acid ethanol, hence it was called NSILA-s. The majority 
of the serum NSILA, about 80 - 90%, was precipitated by 
ethanol, and this fraction was called NSILA-p. This rather 
clear distinction has since been questioned but, what is 
clear is that serum contains several proteins possessing 
insulin-like properties. These include in addition to 
NSILA-s, small molecular weight proteins such as somatome-
dins and nerve growth factors. Poffenbarger, et al (51) 
have also shown a large molecular weight protein (88,000) 
with non-suppressible insulin-like activity. He called 
this "non-suppressible insulin-like protein" or NSILP. It 
has not been determined whether Poffenbarger's NSILP corre-
18 
sponds to Jakob's precipitable large molecular weight frac-
tion. 
NSILA-s 
NSILA-s was shown to be a heat-resistant protein that 
was inactivated by base, cysteine and glutathione ( 7). 
This substance is tightly bound to a carrier protein and 
therefore normally inactive in serum. The active moiety 
dissociates from the complex under acidic conditions. Rind-
erknecht and Humbel (60) were subsequently able to dif-
ferentiate the NSILA-s fraction into two polypeptides of 
like molecular weight (7500). Both protein units exhibited 
non-suppressible insulin-like activity. The amino acid 
sequence of both polypeptides resembled that of proinsulin 
(34). Out of 73 amino acid positions, 45 (62%) were iden-
tical in the two polypeptides (34). Plasma levels of these 
two isomers were shown, to a general degree, to be under the 
control of growth hormone (34). Because of their growth 
promoting abilities, growth hormone dependency (somatomedin 
like), and homology to insulin structure and action, these 
polypeptides were termed Insulin Growth Factor I and II, 
i.e., IGF I and IGF II (60). 
NSILA-s has been shown to stimulate all aspects of 
glucose metabolism in much the same manner as insulin, The 
dose response curves of NSILA-s on glucose uptake and net 
19 
gas exchange were shown to be parallel to those of insulin 
(21). Furthermore, their effects were additive. A few im-
portant differences do exist between NSILA-s and insulin. 
Unlike insulin, NSILA-s or for that matter any of the serum 
proteins possessing insulin-like bioactivity are, for the 
most part, not produced or stored in abundance in a speci-
fie organ. NSILA is not of pancreatic origin (53). Fur-
thermore, NSILA-s has a greater binding affinity to muscle 
(49) and is not inactivated by the liver (49). Oelz, et al 
(49) injected NSILA-s and insulin intravenously in separate 
experiments and found them both to result in a marked hypo-
glycemia. The duration of NSILA-s' in vivo effect, however, 
outlasted that of insulin. The liver's inability to clear 
NSILA-s from the blood and its greater binding affinity 
contributed, no doubt, to the longer duration. 
Present evidence suggests that IGF I and IGF II 
(NSILA-s) do not play a role in the normal regulation of 
glucose homeostasis. Rather they seem to be correlated 
with conditions that are characterized by increased energy 
expenditure, as in diseased states. Increased levels of 
NSILA-s have been shown in extrapancreatic neoplasms with 
severe hypoglycemia ( 8). It is conceivable, therefore, 
that NSILA-s, although a minor fraction, plays an im-
portant role in the provision of energy substrates to the 
body's cells under abnormal conditions. 
20 NSILA-p 
The main fraction of serum NSILA is NSILA-p. This 
large molecular weight substance is not interconvertible 
with the smaller NSILA-s. NSILA-p is a heat labile sub-
h d h 8o oc stance t at enatures at temperatures greater t an 
(35) • It mimics all of insulin's action except on gly-
cogenolysis (48). Dose response curves of NSILA-p on net 
gas exchange and glucose transport, like NSILA-s, were 
parallel and additive to insulin. 
Poffenbarger (51) isolated an 88,000 molecular weight 
glycoprotein consisting of two non-identical chains of 
approximately 42,000 and 46,000 daltons. This "non-sup-
pressible insulin-like protein" or NSILP may account for a 
major portion of serum NSILA. It is probably similar, if 
not identical, to the precipitable large molecular weight 
fraction, NSILA-p, isolated by Jakob, et al (35). Conclus-
ive evidence to the contrary has not been forthcoming. 
Serum ILA under normal conditions has been shown to 
behave as if it were entirely composed of macromolecular 
substances. Rasia, et al (58) were not able to recover 
serum ILA in similar concentrations in lymph, whereas 
serum and lymph IRI were similar. This behavior may be 
attributed to the large size and relative proportion of the 
NSILA-p molecule in the serum. Evidently, under normal 
situations, NSILP and other large molecular weight sub-
stances are restricted to the vascular space. 
It is a well known fact that cardiovascular and 
metabolic inadequacies are manifested in conditions of 
infection, injury and inflammation (11). It is under 
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these conditions of altered vascular function, such as 
increased capillary permeability, that Froesch, et al (18) 
postulated NSILA to cross the capillary membrance and come 
into contact with local tissue. This would, in effect, 
provide additional glucose to the cells in times of urgent 
need. 
One of the foci of this paper is to assess the role, 
if any, of these substances in the blood that display non-
suppressible insulin-like activity, in the hypoglycemia 
seen in the terminal stages of septic shock. Encouraging 
evidence has already been gathered from this laboratory 
implicating an increase in total NSILA levels in late endo-
toxemia (14). 
MATERIALS AND METHODS 
ANIMALS 
Healthy male rats of the Holtzman strain (Holtzman 
Company, Madison, Wi.) weighing 270-370 gm were used. They 
were kept on a diet of Purina Rat Chow (Ralston Purina, 
St. Louis, Mo.) and water for at least a week prior to the 
study. They were acclimated to an ambient temperature of 
22°C (71.6°F) and a 12-hour light-dark cycle (7:00 A.M. -
7:00P.M., CST). All rats were fasted overnight prior to 
experimentation, unless otherwise mentioned. Water was 
provided ad libitum throughout. 
SEPSIS MODEL: CAECAL LIGATION AND PUNCTURE PROCEDURE 
The method introduced by Wichterman, et al (73) for 
the induction of peritonitis in laboratory rats as a model 
of sepsis was adopted and modified for the purposes of 
this study. 
Generally, unless otherwise mentioned, the surgical 
procedure was performed between 8:00 and 10:00 A.M. on 
the day of the study. A midline laparotomy, approximately 
1-2 em in length, was done under ether anesthesia. The 
caecum was exposed and isolated from the abdominal 
cavity. Ligation of the caecum was performed just below 
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the ileocaecal junction with a 3-0 silk ligature (Figure 1) 
(73). Intestinal continuity was later ascertained during 
post-mortem examination by the unimpeded aboral flow of an 
opaque dye originally injected into a region of the ileum 
above the tie. The caecum was punctured twice, through and 
through, with an 18-gauge needle. To ensure patency of the 
perforation and hence, to hasten the infectious process, 
caecal contents were expressed into the peritoneal cavity 
before closure of the incision. The abdominal muscle lay-
ers were sutured closed whereas Michel wound clips were em-
ployed to rejoin the outer skin layer. 
MEASUREMENTS 
The rats were divided into three groups: (1) rats 
whose caeca were ligated and punctured (CLP), as described 
above, (2) rats whose caeca were isolated and replaced 
without being tied or perforated (SHAM), and lastly (3) 
control rats who were fasted but not subjected to surgery 
(FC). 
LETHALITY 
CLP rats were sacrificed by decapitation after their 
righting reflex was judged to be lost, i.e., they would lie 
in the supine position without objection. The loss of this 
reflex was used as an indication of the onset of septic 
shock. SHAM and FC animals were sacrificed at the same 
24 
1 Caecum 
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3 II eo- caecal junction 
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Ligation site 
• Puncture site 
FIGURE 1. Site of caecal ligation and puncture. 
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time as the septic rats to serve as time matched controls. 
CLP rats that were alive 72 hours post operation 
were considered as survivors in preliminary studies. In 
successive experiments, however, the mortality rate was 
determined 16 hours post surgery. Most septic rats were 
in the throes of death at this time. 
Post-mortem examination agreed with the description 
provided by Wichterman, et al (73) of a fluid filled ab-
dominal cavity, engorged and gangrenous caecum, patent 
caecal perforations and no visible presence of stool in the 
abdomen. Cultures done by this group showed a myriad group 
of microorganisms such as Escherichia coli and Proteus 
mirabilis flourishing in the peritoneal fluid (74). No 
effort was made to identify such organisms in this study. 
A qualitative determination of bacterial presence in blood 
was, however, performed and resulted in a positive culture 
from the septic animals. 
PLASMA GLUCOSE 
In the early phase of the study, plasma glucose 
levels were measured prior to surgery and at 8-hour in-
tervals, thereafter, until the rats were sacrificed. This 
group of animals were fasted in the morning (8:00 A.M.) 
and underwent surgery in the afternoon (4:00P.M.). This 
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procedure was identical to the sepsis model of Wichterman, 
et al (73). This set of experiments sought to determine 
the lethality of the model and the progression of blood 
glucose disturbances. In subsequent studies, however, only 
presurgical and terminal levels of plasma glucose were 
measured, as the emphasis of the study focused on glucose 
dyshomeostasis during the agonal stages of septic shock. 
Blood was collected prior to surgery through tail bleeds 
under ether anesthesia. At the time of death, however, 
blood was obtained by decapitation. 
GLUCOSE ANALYZER 
Blood samples were collected in 250 ul heparinized 
micro-centrifuged tubes (Beckman Co., Lincolnwood, Il.) 
over ice and centrifuged. Plasma glucose values, expressed 
in mg of glucose per dl of blood or mg%, were obtained 
directly from a glucose analyzer (Yellow Springs Instru-
ment Model 23A, Yellow Springs, Oh.). 
SERUM IRI 
Blood samples were collected in centrifuge tubes over 
ice at the same time points already mentioned and allowed 
to clot. Subsequent centrifugation (6,000 RPM, IEC PR-J 
centrifuge) allowed the separation of serum from the formed 
elements. 
was done. 
Sera was stored at -20°C until radioimmunoassay 
PHADEBAS INSULIN TEST 27 
Phadebas Insulin Test (Pharmacia Diagnostics, Sweden) 
is a radioimmunoassay based on the Sephadex solid phase 
technique. The insulin in an unknown sample is allowed to 
compete with a fixed amount of an 125 I-labelled insulin for 
the binding sites on highly specific insulin antibodies. 
Bound and free insulin are separated by centrifugation and 
washing. The radioactivity of the bound complex is measur-
edina gamma counter (1185 Series, Nuclear Chicago). The 
amount of bound radioactivity is inversely proportional to 
the amount of insulin present in the sample. Serum IRI 
values are expressed as uU of Insulin per ml of blood. 
IN VITRO DETERMINATION OF GLUCOSE OXIDATION 
Glucose metabolism by the rats' epididymal fat pads 
(EFP) was determined at the time of sacrifice for all three 
groups: CLP, SHAM and FC. Criteria used for sacrifice 
of the septic rat was loss of its righting reflex, as in-
dicated earlier. 
ADIPOSE TISSUE PREPARATIONS 
Subsequent to sacrifice by decapitation, blood was 
collected for serum IRI, PG and NSILA determinations. The 
peripheral segments of the rats' epididymal fat pads (EFP) 
(Figure 2) were quickly excised and placed into a 30 ml 
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1 Right testis 
2 Fat pad 
3 Cauda epididymis 
4 Vas deferens 
• •Sections 
FIGURE 2. Peripheral segments of rat epididymal 
fat pads used in the segmental bioassay 
for basal glucose oxidation, insulin 
responsiveness, and non-suppressible 
insulin-like activity (NSILA). 
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beaker filled with 0.9% saline solution kept at room tern-
perature. These EFP portions (approximate individual 
weight = 500-600 mg) wer~ reduced to several 75-125 mg 
sections and pooled randomly in a petri dish containing phy-
siological saline (53). All EFP segments, thereafter, were 
blotted and weighed before being deposited into metabolic 
(Saba) flasks. Two to three portions of adipose tissue 
were used per incubation vessel to bring the accumulated 
tissue wet weight to about 200 mg (180-225 mg range). The 
entire process, outlined above, from the resection of the 
tissues to their placement into the flasks, took no more 
than 15 minutes. 
C0 2 TRAPPING APPARATUS 
Shortly prior to the placement of the EFP segments 
into the Saba flasks, 5 ml of an equilibrated (95:5 o2 ;co 2 
mixture, pH= 7.4) solution of Krebs Ringer Bicarbonate 
(KRB) buffer (100 ml 0.9% NaCl; 4 ml 1.15% KCl; 3 ml 1.22% 
1.3% NaHC0 3 ) was added. In addition, 100 mg of D-glucose 
14 (Malinckrodt, St. Louis, Mo.) and 50 ul of U- C-D~glucose 
(Amersham, Arlington Hts., Il.) were combined with the 
original KRB solution to bring the final glucose concen-
tration and specific activity in each flask to 1 mg/ml and 
0.5 uCi/ml, respective~y. 
The flasks containing the incubation media were kept 
at room temperature until after the addition of the EFP 
segments and a second aeration of the preparation with a 
95% 0 2 : 5% co 2 mixture for 1 minute. 
The in vitro method of Saba and Diluzio (64) was 
used for the collection of expired co 2 • The EFP segments 
were incubated in capped 50 ml Saba flasks (Kontes Glass 
Co., Vineland, N. J.) for 60 minutes at 37°C in a Dubnoff 
metabolic shaker at a rate of 120 cpm. 
At the end of the incubation period, scintillation 
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vials (Wheaton Scientific, Millville, N. J.) with 24 mm cap 
diameters were fitted into Teflon adapters which, in turn, 
screwed on to the sidearm of the incubation flask. To trap 
14 the released co 2 , strips of Whatman No. 52 filter paper 
saturated with 0.3 ml of Hyamine hydroxide (1.0 M in Meth-
anol, Amersham/Searle) were placed earlier in each scin-
tillation vial. 14 The reaction was stopped and the co 2 re-
leased by the addition of 1 ml of 62.5% citric acid sol-
ution. Recovery of 14 co 2 was allowed to proceed for 15 
minutes after which time, 15 ml of liquid scintillation 
fluor (1 L toluene; 4 gm PPO; 0.1 gm POPOP) was added to 
each vial. It has since been determined that a correction 
factor is necessary to calculate the total evolved 14 co 2 
from a 15-minute collection period. Each vial was subse-
quently counted in a liquid scintillation counter (ISOCAP 
300, Nuclear Chicago) for 20 minutes. 
DATA EXPRESSION AND ANALYSIS 31 
Data was expressed as disintegrations per minute 
(DPM) of 14 co recovered per gram wet weight adipose tissue 2 
per hour of incubation. A computer program was used to 
compensate for a possible decrease in counting efficiency 
due to water evaporization. This program contructed a 
sample channels ratio vs. efficiency curve based upon a 
C-14 standard quench set count rate (Amersham/Searle~ Ar-
lington Hts., Il.). 
Means, standard errors and analysis of variance be-
tween groups were determined using standard computer pro-
grams. 
BASAL GLUCOSE OXIDATION 
Procedure followed was as outlined above for in vitro 
determination of glucose oxidation. 
INSULIN RESPONSIVENESS 
Insulin stimulated glucose oxidation by the EFP seg-
ments from septic, sham and fasted control rats was assess-
ed and compared at the time of death. The segmental EFP 
assay was followed except for the addition of a supra-
stimulatory concentration of insulin (1 mu/ml). Insulin 
solution was prepared fresh (47.3 ug crystalline insulin 
32 
dissolved in 5 ml 0.9% NaCl) during the day of the experi-
ment in siliconized glassware. One hundred ul of this 
solution was added to each flask. 
Duplicate companion flasks without insulin were run 
with a like number of insulin stimulated vessels to serve 
as paired controls for each animal in any given group. 
Data was expressed as DPM 14 co 2 /gm wet weight/hr in-
cubation. A comparison of the glucose metabolism stimu-
lated by insulin was made across the three groups. 
NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY 
The fraction of serum insulin-like activity (ILA) that 
does not lose its activity when treated with anti insulin 
serum is termed as non-suppressible ILA (NSILA) (19). Se-
rum was collected from septic, sham and fasted control rats 
after sacrifice by decapitation. It was oftentimes necess-
ary to pool the rat sera, especially for the septic group 
to attain the desired 1 ml of sera per 5 ml of incubation 
media ratio. The accumulated sera was stored at a temper-
ature of -20°C until needed, 
The assay called for the preincubation of 1 ml of the 
collected sera with 200 ul of guinea pig anti porcine in-
sulin serum, GPAIS (Miles Laboratories, Elkhardt, Ind.) 
0 for 1 hour at 37 c. Following this preincubation period, 
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glucose oxidation was assayed as previously described with 
segmented EFP from fed donor rats (wt. range: 325-350 gm). 
The constituents of the incubation media were varied 
to ascertain total ILA, NSILA and suppressible ILA. Total 
ILA was measured by withholding the addition of GPAIS to 
the KRB-rat serum solution. NSILA was measured by incu-
bating EFP segments in flasks containing 5 ml KRB, 1 ml rat 
sera and 200 ul of GPAIS solution. Suppressible ILA was 
estimated to be the difference between the total ILA and 
NSILA. 
The immunological ILA or immunoreactive insulin (IRI) 
was also measured in these experiments by the Phadebas 
method. 
RESULTS 
LETHALITY 
The preliminary experiments in this study mimicked 
the caecal ligation and puncture method of Wichterman, et al 
(73) to induce general peritonitis. Surgery was performed 
in the afternoon following an 8-hour morning fast. Subse-
quent to the operation a 5 ml/100 gm wt. bolus of 0.9% NaCl 
was injected intramuscularly. This procedure resulted in a 
58.3% (7/12) mortality rate 72 hours post operation. A 
second group of control rats (SHAM) showed 100% (N = 7) sur-
vival rate 72 hours after surgery. This group of rats 
underwent surgery with caecal manipulation but no ligation or 
puncture. 
A modification of Wichterman, et al's (74) procedure, 
i.e., morning surgery following an overnight fast, en-
larged puncture holes, expression of caecal contents prior 
to wound closure and non injection of the 0.9% saline solu-
tion resulted in a hastening of the pathological process. 
Sixteen hours after surgery, 67% (35/52) of caecal ligated 
and punctured (CLP) rats had expired. SHAM (N = 26) and 
fasted control (FC) (N = 24) rats had no lethalities. A 
100% mortality rate was approached 48 hours after the 
surgery for the septic group. 
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PLASMA GLUCOSE AND SERUM INSULIN 
In the earlier experiments, two groups of rats (SHAM 
and CLP) were studied. Blood samples were taken 1 hour 
prior to the operation and at 8-hour intervals thereafter 
until the time of death or sacrifice at 72 hours, whichever 
came first. Figure 3 maps out the plasma glucose pattern 
in SHAM, CLP survivors (CLP-s) and CLP non survivors 
(CLP-ns). The SHAM and CLP-s group of rats maintained 
their plasma glucose at normoglycemic levels of 100 - 120 
mg/dl whereas the CLP-ns rats exhibited plummeting blood 
glucose values. Figure 4 illustrates the terminal glucose 
values for the aforementioned three groups. The CLP-ns 
rats demonstrated a severe hypoglycemia (14.5 ± 4.0 mg/dl) 
upon death. In contrast CLP-s and control SHAM rats were 
at normal fasting levels of 103.7 ± 6.9 and 108.7 ± 3.7, 
respectively. 
Subsequent experiments employed the modification of 
Wichterman, et al's (73) sepsis model. A series of experi-
ments was done to measure plasma glucose levels and serum 
insulin content l hour prior to surgery and at the time of 
death or sacrifice. Three groups were studied: (l) CLP; 
(2) SHAM; (3) FC. As before, the CLP rats were hypo-
glycemic (35.9 ± 2.7 mg/dl) at death whereas both FC and 
SHAM control groups were normoglycemic at 100 ± 1.6 mg/dl 
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FIGURE 3. Plasma glucose levels of sham rats and 
progression to hypoglycemia of septic 
rats. 
See Appendix A for numerical data. 
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FIGURE 4 . Presurgical and terminal plasma glucose levels 
in control and septic (afternoon surgery) rats. 
a 
b 
Blood samples for septic non-survivors (CLP-ns) 
were taken at the time of death; 
Blood samples for septic survivors (CLP-s) and 
sham operated controls (SHAM) were collected 72 
hours post operation. 
Data expressed as MEAN ± S.E.M. 
* CLP-ns vs. CLP-s and CLP-ns vs. SHAM. All signif-
icant comparisons at p less than 0.05. 
See Appendix A for numerical data. 
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and 94.3! 3.9 mg/dl, respectively (Figure 5). Ligated 
and punctured rats that were alive 16 hours after surgery, 
likewise, demonstrated not significantly different blood 
glucose value of 105.9 ! 4.9 mg/dl. 
Terminal serum immunoreactive insulin (IRI) content 
for the three groups; FC, SHAM and CLP did not vary from 
each other (Figure 6). No significant difference was 
found to exist between groups at the same time point. 
There was a difference, however, between the presurgical 
and terminal IRI levels. The significance of this will be 
discussed later. 
BASAL GLUCOSE OXIDATION 
Peripheral tissue glucose oxidation was assessed for 
all three groups: FC, SHAM and CLP. Table 1 illustrates 
the hypoglycemia and enhanced adipose tissue glucose u-
tilization in the agonal stages of sepsis. The oxidation 
of 14 c - glucose to 14 co 2 by the septic rat's epididymal 
fat pads was significantly greater than either SHAM or FC 
control group (56.3 ± 6.4 vs. 35.0 ! 3.3 or 24.5 ! 2.4 
10 3 14 co dpm/g/hr) in vitro. 2 Although the measured glu-
case oxidation value for the SHAM group was greater than 
the unoperated rats (FC), analysis of variance showed no 
significant difference to exist. 
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samples were taken after simultaneous sacrifice 
with dying septic rats. 
CLP survivor plasma glucose levels taken 16 
hours post operation. 
Data expressed as MEAN ± S.E.M. 
* Significant difference at p less than 0.05. 
See Appendix B for numerical data. 
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One Hour Terminal 
Pre-Operation 
A All rats one hour prior to surgery 
B - Septic non-survivor (CLP-ns) group 
C - Surgical control (SHAM) group 
D - Fasted control (FC) group 
Presurgical and terminal serum immuno-
reactive insulin (IRI) concentration in 
control and septic (morning surgery) rats. 
Data expressed as MEAN ± S.E.M. 
No significant differences between groups 
at p greater than 0.05. 
See Appendix C for numerical data. 
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TABLE 1 
IN VITRO BASAL GLUCOSE OXIDATION BY SEPTIC 
AND CONTROL EPIDIDYMAL FAT PADS 
Groups Plasma Glucose 
(mg/dl) 
1. CLP 40.2 ± 3.0 a 
N = 32 
2. SHAM 97 ± 2.0 
N = 33 
3. FC 96.5 ± 2.5 
N = 32 
Data expressed as MEAN ± S.E.M. 
Glucose Oxidation 
(10 3 14 co dpm/g/hr) 2 
56.3 ± 6.4 a 
35.0 ± 3.3 
24.5 ± 2.4 
a CLP vs. SHAM, CLP vs. FC. Significant comparisons. 
ANOVA at p less than 0.05. 
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INSULIN RESPONSIVENESS 
Filkins and Figlewicz (17) had shown that the adipose 
tissue of endotoxic rats was hyperresponsive to a given 
stimulus of insulin in vitro. They suggested this as a 
possible mechanism for the enhanced peripheral tissue glu-
case oxidation. The responsiveness of the septic rat's 
epididymal fat pads was assessed in this study by the ad-
clition of a supra stimulatory concentration of insulin 
(1 mU/ml) in vitro. As mentioned earlier, the basal glu-
case oxidation, in vitro, of adipose tissue excised from 
septic rats catabolized glucose at a higher rate than 
either control group (42.1 ± 4.2 vs. 23.9 ± 2.0, 17.8 ± 
3 14 1.9 10 co 2 dpm/g/hr). Table 2 also shows that upon ad-
clition of 1 mU/ml of insulin into the incubation media, the 
septic rats' fat pads were further stimulated to a greater 
value of glucose oxidation than either SHAM or FC group. 
Statistical analysis showed these differences to be signif-
cant. 
NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY 
Along with the aberration of tissue responsiveness, 
recent work from our laboratory has shown the possibility 
of non-suppressible insulin-like activity (NSILA) as an 
important factor in glucose homeostasis in infectious 
states (14). A modification of Poffenbarger's segmental 
TABLE 2 
EFFECT OF INSULIN, IN VITRO, ON SEPTIC AND CONTROL 
Groups 
1. CLP 
2. SHAM 
3 • FC 
EPIDIDYMAL FAT PAD GLUCOSE OXIDATION 
PGb 
(mg/dl) 
52.6 ± 6.9a 
(18) 
90.3 ± 1.8 
(14) 
93.7 ± 3.42 
( 17) 
Glucose Oxidation 
(10 3 14 co dpm/g/hr) 2 
Basal 
c 
(0 mU/ml) 
42.1 ± 4.2a 
(18) 
23.9 ± 2.0 
(16) 
17.8 ± 1.9 
(16) 
Stimulated 
c (1 mU/ml) 
104.7 ± 11.8a 
(18) 
71.8 ± 11.0 
(15) 
56.6 ± 4.9 
(15) 
Data expressed as MEAN ± S.E.M. 
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a CLP vs. SHAM, CLP vs. FC. All significant comparisons. 
ANOVA at p less than 0.05. 
b PG: Plasma Glucose 
c Insulin concentration 
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bioassay for NSILA was employed in this study. The epi-
didymal fat pads from fed donor rats were incubated under 
three separate conditions: (1) in Kreb's Ringer bicar-
bonate buffer (KRB) alone, (2) KRB + test serum and lastly, 
(3) KRB + test serum + Guinea Pig Anti Insulin Serum 
(GPAIS). The first group served as control, and the second 
and third were for assessing total ILA and NSILA, respect-
ively. The presence of CLP, SHAM or FC sera in the media 
significantly elevated the fat pad glucose oxidation (Table 
3). This indicated the presence of insulin and insulin-
like substances in the sera of all three rat groups. IRI 
was measured and no significant difference was found be-
tween the septic and control groups. When the GPAIS was 
added along with serum into the media to assess NSILA, CLP 
sera demonstrated a greater level of activity than SHAM or 
FC sera. Glucose oxidation did not vary in the presence 
or absence of GPAIS in either CLP or FC group. There was 
a marked reduction, however, if GPAIS was added to a prep-
aration with sera from SHAM rats. The relevance of these 
observations will be discussed in the next section. 
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TABLE 3 
COMPARISON OF NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY 
GROUPS 
1 
CLP 
2 
SHAM 
3 
FC 
a 
b 
IN THE SERA OF SEPTIC AND CONTROL RATS 
Glucose Oxidationc 
(103 14co dpm/g/hr) 2 
IRib,d 
(uU/ml) 
KRB 
only 
KRB + KRL + SERUM 
serum + GPAIS 
32.8 ± 3.6 
( 8) 
90.6 ± 3.3 
(12) 
92.4 ± 4.0 
(10) 
18.8 :t 2.0 
(10) 
15.6 ± 1. 3 
(10) 
14.4 ± 1.1 
(10) 
Data expressed as MEAN ± S.E.H. 
38.2 ± 1.5 
(63) 
84.1 :: 9. 9 
( 7) 
90.0 ± 13.5 
(11) 
48.3 ± 6.0 
(11) 
CLP vs. SHAH, CLP vs. FC, SHAM vs. FC. All significant 
comparisons ANOVA at p less than 0.05. 
No significant difference in IRI, p greater than 0.05, 
88.5 ± 8.0a 
(7) 
67.8 ± 5.2a 
(26) 
50.8 ± 4.0a 
(28) 
c Numbers in parentheses denote number of assays run. 
d Numbers in parentheses denote number of animals 
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DISCUSSION 
SEPSIS MODEL EFFICACY 
The effectiveness of the caecal ligation and puncture 
(CLP) model to induce peritonitis was assessed through the 
lethality rate and incidence of hypoglycemia. As stated 
earlier, 67% of CLP rats died 16 hours post surgery. This 
was comparable to a 75% (138/184) mortality rate reported 
by Wichterman, Baue and Chaudry (73) for similarly treated 
rats (caecal ligation + 2 punctures with an 18-gauge needle) 
after 24 hours. In the present modification of their model, 
the majority of the animals died 8 - 16 hours following the 
surgery. This model is significantly more rapid and lethal 
than the model Wichterman, et al (73) first proposed. 
PLASMA GLUCOSE AND SERUM INSULIN LEVELS 
As illustrated by both Figures 4 and 5, the septic rats 
died in a state of metabolic decompensation, viz., hypo-
glycemia. Although CLP (caecal ligation and puncture) rats 
that underwent morning surgery showed a less severe hypo-
glycemia (35.9 ± 2.7 mg/dl) than their afternoon counterpart 
(14.5 ± 4.0), the former was the method of choice because 
of sampling ease since the bulk of deaths (67%) (35/52) oc-
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curred within a narrow time period (8 - 16 hours post sur-
gerv). The measurement of low blood glucose agrees well 
with previous works in the literature for rats in the ag-
onal or hvpodvnanic sta?.es of endotoxemia and sepsis 
(14.74). It can also be seen from Figures 3. 4 and 5 that 
the survival of an animal was reflected bv his abilitv to 
maintain a status of normoglvcemia. These data concur with 
work bv Hinshaw. et al (31) and Filkins and Cornell (16). 
Figure 6 illustrates that no significant difference 
existed between the three grouns of animals (CLP. SHAM and 
FC) in serum insulin content at the time of death. There 
was. however. a difference in insulin levels when the term-
inal readings for the three groups of animals were compared 
to pre-surgical levels. This difference may be due to the 
slightly higher level of plasma glucose before surgery and 
also to the blood sampling method under ether anesthesia. 
Furthermore, pre-surgical glucose and insulin levels were 
taken at a point closer in time to the initial withholding 
of food than terminal samples. 
This finding of no significant difference between con-
trol (SHAM and FC) and septic (CLP) rats' insulin content 
does not fully agree with previous work by Ryan, et a! (16) 
and Filkins (14). Ryan, et al (16) found 72 hours septic 
fasted rats to have a threefold higher level of insulin 
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than 72-hour fasted control rats. A recent study by Fil-
kins (14) showed the opposite to be true in late endotoxic 
shock. He showed a hypoinsulinemia (9.2 ± 3.8 uU/ml vs. 
control value of 36 ± 6) to occur prior to the animal's 
death. The difference in measured insulin concentration 
between this study and those previously mentioned may be 
due to a number of factors such as: (1) mode of induction 
of infection (caecal ligation vs. caecal ligation and punc-
ture vs. endotoxin injection), and (2) stage of progression 
of the infectious process. Ryan, et al (63) showed no hypo-
glycemia to exist in their study, whereas Filkins (14) dem-
onstrated blood glucose levels of 41 ± 8 mg/dl. It seems 
evident, therefore, that Ryan, et al's results were taken 
prior to metabolic decompensation whereas this study's re-
sults and Filkins (14) were taken during the hypoglycemic 
depression. Wichterman, et al (74) measured insulin con-
tent to be 21 ± 5 uU/ml in rats in late sepsis and this 
agrees well with this study's insulin quantitation. 
ENHANCED PERIPHERAL TISSUE GLUCOSE OXIDATION 
Numerous studies in the past have repeatedly shown 
the hypercatabolism of glucose during the infectious pro-
cess (17,63,71). This increased utilization of glucose 
appears early on in endotoxicosis as a result of hypergly-
cemia and associated hyperinsulinemia (6). Ryan, et al 
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(63) has similarly shown this to occur in the fat pads of 
septic rats. The hypercatabolism of glucose continues, 
however, until the later stages of endotoxic or septic 
shock (17,32,71). The result of this study provides fur-
ther evidence for the hypoglycemic action of increased glu-
cose utilization. Table 1 shows the markedly greater oxi-
dation of 14 c - glucose to 14 co and associated hypogly-2 
cemia in septic animals. 
Two mechanisms for this hypercatabolism suggested by 
Filkins and Figlewicz (17) and Filkins (14) were investi-
gated further in this study; (1) tissue hyperresponsiveness 
to insulin and (2) non-suppressible insulin-like activity. 
INSULIN RESPONSIVENESS 
The responsiveness of the septic rats' adipose tissue 
was ascertained, in vitro, by the addition of a suprastim-
ulatory dose (1 mU/ml) of insulin to the incubation media. 
Table 2 shows that the added insulin stimulus drives the 
septic (CLP), sham operated (SHAM) and fasted control (FC) 
rats' fat pads to approximately three times the basal level. 
Insulin further stimulated the already hypercatabolic sep-
tic rats' fat pads such that, empirically, both basal and 
stimulated glucose oxidation rates for the CLP group were 
significantly greater than SHAM or FC. This in itself does 
not indicate an altered sensitivity by the septic rats' 
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adipose tissue to insulin. These results, however, agree 
with the findings of Filkins and Figlewicz (17) of in-
creased adipose tissue insulin responsiveness in endotoxic 
rats. One of the criteria satisfied to imply an alteration 
in insulin responsivity has been the antagonism of insulin 
action by ATP. Chang and Cuatrecasas ( 9) had shown that 
the addition of 10-4 and 10-S M ATP to the incubation media 
decreased the responsiveness of isolated adipocytes to 
insulin. This in vitro experiment was not done in this 
study, however, an in vivo study by Chaudry, et al (10) had 
already shown, using the same experimental model of sepsis, 
the prevention of hypoglycemia and increased survivability 
following the administration of ATJ-MgC1 2 and glucose. It 
is not unreasonable, therefore, to cautiously suggest that 
adipose tissue insulin responsiveness is altered in septic 
as well as endotoxic shock. 
NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY (NSILA) 
Serum contains several proteins possessing insulin-
like properties. One of these entities, non-suppressible 
insulin-like activity (NSILA) is of interest in this study 
since Filkins (14) showed increased levels of NSILA assoc-
iated with the terminal hypoglycemia in endotoxicosis. The 
NSILA assay employed in this study did not make any dis-
tinction between soluble (NSILA-s) and precipitable (NSILA-p) 
portions. 
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Table 3 illustrates significant insulin-like activity 
(ILA) in serum after its addition to the incubation media. 
Total serum ILA may be gauged by comparing glucose oxi-
dation rates between assays in the presence and absence of 
serum in the incubation media. As Table 3 shows, sera from 
rats that underwent surgery, CLP and SHAM, exhibited great-
er total ILA activity than fasted and hydrated (FC) rats. 
This may be attributed to the slightly higher values of 
immunoreactive insulin (IRI) and NSILA in the former two 
groups. Statistical testing shows, however, no significant 
difference to exist in insulin content. One notices that 
these insulin values are lower than what was previously re-
ported in this study. This discrepancy is perhaps due to 
variation within this strain since all the animals in this 
shipment demonstrated lower serum insulin content. 
All three groups of rats exhibited non-suppressible 
insulin-like activity as illustrated by the increase in glu-
cose oxidation despite the presence of Guinea Pig Anti Por-
cine Insulin Serum (GPAIS) in the media. The level of NSILA, 
in descending order, is as follows: CLP, SHAM and FC. 
These results support Filkins' finding of increased NSILA 
levels in the late stages of endotoxic shock (14). NSILA 
has been associated with hypoglycemia in various disease 
processes ( 8 , 45). Froesch, et al (47) have suggested a 
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probable role for NSILA in the provision of energy sub-
strates in conditions of vascular collapse. Since sepsis 
and endotoxemia both involve vascular as well as metabolic 
lesions, it is a plausible supposition that NSILA as well 
as altered tissue insulin responsiveness play a deciding 
role in the progression to hypoglycemia. The hypothesis 
extended here is that the hypoglycemia seen in the agonal 
stages of sepsis may, in part, be attributed to an in-
crease in the level of substances in the blood and in-
terstitial spaces which are physicochemically distinct, yet 
bioactively similar to insulin. 
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SUMMARY OF CONCLUSIONS 
1. Induction of septic shock through caecal ligation 
and puncture is a sufficiently lethal and appro-
priate model for metabolic studies in infectious 
processes. 
2. Late stage of sepsis was characterized by hypogly-
cemia. Normal blood glucose level is correlated 
to the survival of an animal after a septic 
episode. 
3. There was no demonstrable difference in the serum 
insulin concentration of septic, sham operated 
and fasted control rats at the time of death. 
4. There was a significantly higher rate of glucose 
oxidation in septic adipose tissue as compared to 
sham operated and fasted control rats. 
5. Addition of insulin, in vitro, equally led to a 
threefold increase in glucose oxidation rates by 
the fat pads from all three groups. 
6. Increased level of NSILA in septic rats as com-
pared to both control groups suggest a prominent 
role for NSILA in the development of hypoglycemia. 
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APPENDIX A 
PRESURGICAL AND TERMINAL PLASMA GLUCOSE LEVELS IN 
CONTROL AND SEPTIC (AFTER.NOON SURGERY) RATS 
Plasma Glucose 
(mg/dl) 
Groups 
All Rats 
One Hour 
Preoperation Terminal 
1. CLP-ns 14.5 ± 4.0 
(N=7) 
2 • CLP-s 151.5 :!: 5. 7 103.7 ± 6. 9 
(n=5) (N=l9) 
3. SHAM 108.7 ± 3. 7 
(N=7) 
Data expressed as MEAN :!: S.E.M. 
CLP-ns Septic non-survivor group 
CLP-s Septic survivor group 
SHAM Surgical control group 
a CLP-ns vs. CLP-s and CLP-ns vs. SHAM : Significant 
comparisons through analysis of variance, p less 
than 0.05. 
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APPENDIX B 
PRESURGICAL AND TERMINAL BLOOD GLUCOSE LEVELS 
IN CONTROL AND SEPTIC (MORNING SURGERY) RATS 
Plasma Glucose 
All Rats 
One Hour 
Groups Preoperation Terminal 
1. CLP-ns 35.9 ± 2.7a 
(N-35) 
2. CLP-s 105.9 ± 4.9 
(N=l7) 108.6 ± 1.03 
3. SHAM (N=l02) 94.3 ± 3. 9 
(N=26) 
4 . FC 101.0 ± 1.6 
(N=24) 
Data expressed as MEAN ± S.E.M. 
FC : Fasted control group 
a CLP-ns vs. CLP-s, CLP-ns vs. SHAM, CLP-ns vs. 
FC : All significant comparisons through 
ANOVA, p less than 0.05. 
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PRESURGICAL AND TERMINAL SERUM IMMUNOREACTIVE 
INSULIN CONCENTRATION IN SEPTIC (MORNING 
SURGERY) NON-SURVIVOR AND CONTROL RATS 
Serum Immunoreactive Insulin 
(uU/ml) 
Groups 
All Rats 
One Hour 
Preoperation Terminal 
1. CLP 24.7 ± 2. 5 
2. SHAN 33.3 ± 2. 1 24.5 ± 2. 7 
(N=40) (N=21) 
3. FC 22.1 ± 2.4 
(N=22) 
Data expressed as MEAN ± S.E.M. 
CLP : Septic non-survivor group. 
No significant difference bet~een groups. 
Anova less than 0.05. 
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